استمتع بـUnlimited مع Magzter GOLD
احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل
يحاول ذهب - حر
Mankind Gets Nod for Trials of Novel Autoimmune Drug
September 09, 2025
|Business Standard
Mankind Pharma has received approval from the Central Drugs Standard Control Organisation to initiate phase-1 clinical trials of its novel autoimmune drug candidate, the company said on Monday.
The molecule, MKP11093, an orally administered Janus Kinase-1 (JAK-1) inhibitor, is being developed for the treatment of multiple autoi
هذه القصة من طبعة September 09, 2025 من Business Standard.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Business Standard
Business Standard
Affordable housing gets out of pocket
Despite policy boosts, land costs and lender parity issues are driving the sector off-script, reports Raghu Mohan
4 mins
December 01, 2025
Business Standard
'Despite digital transactions, ATM demand remains strong'
Oki Electric Industry Co, or OKI, has been selling automated teller machines (ATMs) in India for a decade.
3 mins
December 01, 2025
Business Standard
Kicking climate can down the road
The world cannot afford one more climate summit to forge a weak outcome
4 mins
December 01, 2025
Business Standard
GDP beats expectations
Nominal growth numbers may pose challenges
2 mins
December 01, 2025
Business Standard
Deutsche Bank rewires its GCC playbook
New India GCC CEO to push leadership, and AI roles
3 mins
December 01, 2025
Business Standard
OTTs may drive up to 10% growth for South cinema dubbing rights in 2026
With the rise in prominence of pan-Indian films and streaming platforms focusing on sustaining subscriber stickiness, dubbed rights for South Indian films are expected to rise up to 10 per cent next year as they attract eyeballs beyond their mainstay markets with compelling storylines and talent.
1 mins
December 01, 2025
Business Standard
After robust H1, economists upgrade full-yr FY26 growth forecast to 7.5%
With the first half (H1) gross domestic product (GDP) growth clocking 8 per cent, most economists have now upgraded their full-year 2025-2026 (FY26) growth forecast to 7.5 per cent, or above.
2 mins
December 01, 2025
Business Standard
The strongest shield against cyber fraud
Over the past decade, the way we transact has changed dramatically: Cash is being replaced by digital wallets, the Unified Payments Interface (UPI) and mobile banking apps.
2 mins
December 01, 2025
Business Standard
'Need anti-dumping duties on Chinese excavators, cranes'
The Indian government should urgently consider imposing safeguard or anti-dumping duties on imports of two construction equipment segments — crawler excavators and tower cranes —as Chinese companies are rapidly expanding their presence in these markets in India through ‘predatory’ pricing supported by lower raw material costs, substantial export subsidies, and extended credit schemes, said Sorab Agarwal, executive director at Action Construction Equipment (ACE).
2 mins
December 01, 2025
Business Standard
Tackling urban pollution
A binding national plan is urgently needed
2 mins
December 01, 2025
Listen
Translate
Change font size